Twist Bioscience Corporation Sustainability Profile
Twist Bioscience Corporation, commonly referred to as Twist Bioscience, is a pioneering synthetic biology company headquartered in the United States. Founded in 2013, the company has rapidly established itself as a leader in the biotechnology sector, focusing on DNA synthesis and gene editing technologies. With major operational regions across North America and Europe, Twist Bioscience serves a diverse range of industries, including pharmaceuticals, agriculture, and industrial biotechnology. The company’s core offerings include high-quality, scalable DNA synthesis solutions that are distinguished by their precision and efficiency. Twist Bioscience's innovative approach to DNA manufacturing has garnered significant recognition, positioning it as a key player in the synthetic biology market. Notable achievements include partnerships with leading research institutions and a commitment to advancing genetic research, making Twist Bioscience a vital contributor to the future of biotechnology.
DitchCarbon Score
How does Twist Bioscience Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Twist Bioscience Corporation's score of 30 is higher than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Twist Bioscience Corporation's reported carbon emissions
In 2024, Twist Bioscience Corporation, headquartered in the United States, reported total carbon emissions of approximately 3,007,000 kg CO2e. This figure includes about 7,000 kg CO2e from Scope 1 emissions and approximately 3,000,000 kg CO2e from Scope 2 emissions. Notably, the company has not disclosed any Scope 3 emissions data. Twist Bioscience is committed to reducing its carbon footprint, having established near-term targets as part of its climate strategy. While specific reduction targets have not been detailed, the company is classified as "Committed" under the Science Based Targets initiative (SBTi), indicating a proactive approach to climate commitments. The company operates within the Pharmaceuticals, Biotechnology, and Life Sciences sector, and its emissions data reflects its ongoing efforts to address climate change. As of now, there are no long-term targets or net-zero commitments publicly stated.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2024 | |
|---|---|
| Scope 1 | 7,000 |
| Scope 2 | 3,000,000 |
| Scope 3 | - |
How Carbon Intensive is Twist Bioscience Corporation's Industry?
How Carbon Intensive is Twist Bioscience Corporation's Location?
Twist Bioscience Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Twist Bioscience Corporation has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Affymetrix Inc.
Frequently Asked Questions
Common questions about Twist Bioscience Corporation's sustainability data and climate commitments
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.